Evidence map›Paper›PMID 27013550›Full record

ArticleDNA research : an international journal for rapid publication of reports on genes and genomes2016

Comprehensive identification of translation start sites by tetracycline-inhibited ribosome profiling.

Kenji Nakahigashi, Yuki Takai, Michiko Kimura, Nozomi Abe, Toru Nakayashiki, Yuh Shiwa, Hirofumi Yoshikawa, Barry L Wanner, Yasushi Ishihama, Hirotada Mori

Open access · goldAbstract read
In one paragraph

Article in DNA research : an international journal for rapid publication of reports on genes and genomes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Synthetic genomes unveil the effects of synonymous recoding.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Frontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Kenji NakahigashiInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0017, Japan knakahig@pobox.com hmori@gtc.naist.jp.
Yuki TakaiInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0017, Japan.
Michiko KimuraGraduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Nozomi AbeInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0017, Japan.
Toru NakayashikiGraduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara 630-0101, Japan.
Yuh ShiwaGenome Research Center, NODAI Research Institute, Tokyo University of Agriculture, Tokyo 156-8502, Japan.
Hirofumi YoshikawaGenome Research Center, NODAI Research Institute, Tokyo University of Agriculture, Tokyo 156-8502, Japan Department of Bioscience, Tokyo University of Agriculture, Tokyo 156-8502, Japan.
Barry L WannerDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.
Yasushi IshihamaGraduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Hirotada MoriGraduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara 630-0101, Japan knakahig@pobox.com hmori@gtc.naist.jp.
Keio University · JPKyoto University · JPNara Institute of Science and Technology · JPTokyo University of Agriculture · JPHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetracycline-inhibited ribosome profiling (TetRP) provides a powerful new experimental tool for comprehensive genome-wide identification of translation initiation sites in bacteria. We validated TetRP by confirming the translation start sites of protein-coding genes in accordance with the 2006 version of Escherichia coli K-12 annotation record (GenBank U000962) and found ∼150 new start sites within 60 nucleotides of the annotated site. This analysis revealed 72 per cent of the genes whose initiation site annotations were changed from the 2006 GenBank record to the newer 2014 annotation record (GenBank U000963), indicating a high sensitivity. Also, results from reporter fusion and proteomics of N-terminally enriched peptides showed high specificity of the TetRP results. In addition, we discovered over 300 translation start sites within non-coding, intergenic regions of the genome, using a threshold that retains ∼2,000 known coding genes. While some appear to correspond to pseudogenes, others may encode small peptides or have previously unforeseen roles. In summary, we showed that ribosome profiling upon translation inhibition by tetracycline offers a simple, reliable and comprehensive experimental tool for precise annotation of translation start sites of expressed genes in bacteria.

Indexed as

Codon, InitiatorOpen Reading FramesEscherichia coliMolecular Sequence AnnotationProtein Synthesis InhibitorsRibosomesTetracyclineCodon, InitiatorProtein Synthesis InhibitorsTetracyclinegenome annotationN-terminalribosome profilingTetRPtranslation initiation

Identifiers

PMID27013550
PMCPMC4909307
OpenAlexW2310979666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.